Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH
15.88
-0.62(-3.76%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
15.88
-0.62(-3.76%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8221
First IPO Date
March 04, 2003
| Name | Title | Pay | Year Born |
| Bao Hua Chen | GM, President & Director | 0 | 1962 |
| Bin He | Vice President | 0 | 1976 |
| Bo Xu | Vice President | 0 | 1973 |
| Qi Mao Chen | Vice President | 0 | 1958 |
| Lihong Lin | Vice President | 0 | 1977 |
| Mi Xu | Vice President | 0 | 1983 |
| Yanhua Meng | Vice President | 0 | 1979 |
| Sijia Guo | Executive Vice President & Director | 0 | 1963 |
| Yong Hua Zhu | Vice President, Secretary of the Board & Director | 0 | 1965 |
| Mei Zhang | Senior Vice President & Chief Financial Officer | 0 | 1976 |
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.